Anthropic Eyes $6B Decart AI Acquisition Ahead of Mega IPO 
Asian Stocks Rally as Cooling US Inflation Boosts Fed Rate Outlook 
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case 
Tabletop particle accelerator could transform medicine and materials science 
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency 
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets 
Blue Origin New Glenn Explosion Could Delay Launch Operations Until 2028 
FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
BSP Sees Philippine Inflation Easing, Keeps Policy Options Open 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
S&P 500 Hits Record High as Soft Inflation Data Eases Fed Rate Hike Fears 
S&P 500 Retreats From Record High as AI Stocks Slide, Retail Sales Disappoint 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Add as a preferred source on Google
South Korean scientists have developed an artificial intelligence (AI)-based peptide detection model that can predict the antibiotic functionality of peptides antibiotic for hay bacillus, colon bacillus, staphylococcus aureus, and staph.
The research team from the National Institute of Biological Resources and Dongguk University applied the AI model that learned antibiotic peptide data for the transcriptome of the wolf spider’s venom gland and succeeded in exploring two types of new antibiotic peptides.
The spider venom’s peptide has the property of destroying cells and paralyzing nerves, and can thereby be used as a functional material in various areas, including medicines, food, and cosmetics.
